Stock listing

NASDAQ:BIVV Bioverativ Inc Stock

Follow Bioverativ Inc into a list and get an email when it puts out news.

Last close · NASDAQ:BIVV

$104.98 USD

Close on Mar 8, 2018 · No longer trades

Feb 2, 2017 to last close +133.4% · daily closes, Feb 2, 2017 – Mar 8, 2018
Lowest – highest close
$42.40 – $104.98 USDSince Feb 2, 2017 · lowest Feb 9, 2017 · highest Mar 8, 2018

Delisted NASDAQ:BIVV no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:BIVV
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Bioverativ Inc on 6ix

Decks
1 deck · latest Jan 6, 2017

Decks

DeckKindSlidesDate
Investor Day (January 2017)Investor day50 slidesJan 6, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alexander J Denner
Other companies: Ironwood Pharmaceuticals, Inc. (Director · Since at least Nov 9, 2020); The Medicines Company (Director · Feb 2, 2016 – Jan 6, 2020 · Past); Ariad Pharmaceuticals Inc (Director · Feb 20, 2014 – Feb 16, 2017 · Past); VIVUS Inc (Director · Aug 14, 2013 – Oct 30, 2015 · Past); Biogen Inc. (Director · Jun 10, 2009 – Jun 15, 2022 · Past); Amylin Pharmaceuticals LLC (Director · Jun 9, 2009 – Aug 8, 2012 · Past); Viskase Holdings, Inc. (Director · May 21, 2009 – Jan 2, 2013 · Past); Savara, Inc. (Director · Oct 26, 2006 – Oct 16, 2009 · Past)
Director · Jan 10, 2017 – Mar 8, 2018 · Past
Coelho Rogerio Vivaldi
Other companies: Viatris Inc. (Director · Since at least Jun 3, 2024); Crinetics Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2022); Sigilon Therapeutics Inc (PRESIDENT AND CEO, Director · Dec 3, 2020 – Aug 11, 2023 · Past); Spark Therapeutics Inc (Chief Commercial Officer · Jan 29, 2015 – Jul 15, 2016 · Past); Minerva Neurosciences, Inc (President and CEO, Director · Jun 30, 2014 – Jun 30, 2014 · Past)
EVP, Chief Global Therapeutics · Dec 22, 2016 – Mar 8, 2018 · Past
Geno Germano
Other companies: Harmony Biosciences Holdings, Inc. (Director · Since at least Apr 2, 2026); Entera Bio Ltd. (Chairman of the Board · Since at least Feb 4, 2026); Precision BioSciences, Inc. (Director · Since at least Mar 10, 2020); Sage Therapeutics Inc (Director · Since at least Jun 6, 2018); The Medicines Company (Director · Nov 9, 2017 – Jan 6, 2020 · Past)
Director · Jan 31, 2018 – Mar 8, 2018 · Past
Richard Brudnick
Other companies: InflaRx N.V. (Board Member · Since at least Mar 18, 2026); Scholar Rock Holding Corporation (Director · Since at least Apr 6, 2023); Prime Medicine, Inc. (Chief Business Officer · Oct 19, 2022 – May 20, 2025 · Past); VolitionRx Limited (Director · Mar 25, 2021 – Jan 12, 2023 · Past); Codiak BioSciences Inc (See Remarks · Oct 13, 2020 – Feb 16, 2022 · Past)
EVP, Business Development · Dec 22, 2016 – Mar 8, 2018 · Past
Anna Protopapas
Other companies: Nuvalent, Inc. (Director · Since at least Mar 30, 2022); Mersana Therapeutics Inc (Director · Since at least Jun 27, 2017); Dicerna Pharmaceuticals Inc (Director · Jan 23, 2019 – Jun 3, 2021 · Past); Ariad Pharmaceuticals Inc (Director · Feb 1, 2016 – Feb 16, 2017 · Past)
Director · Feb 28, 2017 – Mar 8, 2018 · Past
John Cox
Other companies: Dyne Therapeutics, Inc. (President and Chief Executive Officer · Since at least Mar 25, 2024); Sigilon Therapeutics Inc (Director · Dec 3, 2020 – Aug 11, 2023 · Past); Repligen Corporation (Director · Nov 15, 2013 – Mar 24, 2020 · Past); Biogen Inc. (EVP Pharmaceutical Oper & Tech · Nov 1, 2011 – Apr 1, 2016 · Past)
Chief Executive Officer, Director · Dec 22, 2016 – Mar 8, 2018 · Past
John Greene
Other companies: Northrop Grumman Corporation (Corporate Vice President and Chief Financial Officer · Since at least Jan 7, 2026); CRISPR Therapeutics AG (Director · Since at least Jun 11, 2019); Discover Financial Services (EVP, Chief Financial Officer · Sep 18, 2019 – May 18, 2025 · Past); Willis Towers Watson Public Limited Company (Chief Financial Officer · Jun 2, 2014 – Nov 9, 2015 · Past)
EVP, CFO and Treasurer · Dec 22, 2016 – Mar 8, 2018 · Past
Lucia Celona
Other companies: Dyne Therapeutics, Inc. (Chief Human Resources Officer · Since at least Nov 5, 2026); Apellis Pharmaceuticals, Inc. (See Remarks · Aug 5, 2019 – Feb 10, 2020 · Past)
EVP, HR & Corp Commun. Officer · Dec 22, 2016 – Mar 8, 2018 · Past
Timothy Harris
Other companies: BG Medicine Inc (Director · Since at least Feb 3, 2011); CapForce Inc. (Director · May 4, 2015 – Jun 13, 2018 · Past)
EVP, R & D · Apr 10, 2017 – Mar 8, 2018 · Past
Andrea DiFabio
Other companies: Xenon Pharmaceuticals Inc. (Chief Legal Officer and Corporate Secretary · Since at least Nov 7, 2022)
EVP, Chief Legal Officer · Dec 22, 2016 – Mar 8, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about Bioverativ Inc.